Adinazolam

This page contains recent news articles, when available, and an overview of Adinazolam but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Overview:

Adinazolam (when available)

Pharmacology and use:
Adinazolam is a benzodiazepine derivative used to treat anxiety, status epilepticus, and for sedation induction and anterograde amnesia. Adinazolam binds with high affinity to the GABA benzodiazepine receptor complex. Considerable evidence suggest that the central pharmacologic/therapeutic actions of alprazolam are mediated via interaction with this receptor complex. For treatment of panic disorder

Mechanism Of Action:
Adinazolam binds to peripheral-type benzodiazepine receptors which interact allosterically with GABA receptors. This potentiates the effects of the inhibitory neurotransmitter GABA, increasing the inhibition of the ascending reticular activating system and blocking the cortical and limbic arousal that occurs following stimulation of the reticular pathways.

News Articles on Adinazolam

Brand Names/Synonyms:
Adinazolam is also known by the following brand names and/or synonyms:
ADINAZOLAM; Adinazolam [Usan:Ban:Inn]; Adinazolam [Usan]; Adinazolamum [Inn-Latin]; U 41123

Drug Category:
Adinazolam is categorized under the following by the FDA: Antidepressants; ATC:N05BA07

Dosage Forms:
Not Available

Absorption:
Not Available

Interactions:
[an error occurred while processing this directive]

Chemical IUPAC Name:
Not Available

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.